drug resistant tb

LONDON (AP) -- The World Health Organization says the highest levels ever of drug-resistant tuberculosis have been found in Russia and Moldova....

Highest level of drug-resistant TB found in Europe Experts said trends in drug-resistant TB in most countries "are still unclear." In research published in the February edition of WHO's journal, Bulletin, experts reported that about 29 percent of new TB patients in parts of Russia were drug-resistant.

Doctors in India are reporting disturbing news — 12 patients with “totally drug-resistant” tuberculosis.

The patients diagnosed with the lung disease have been treated with conventional medications to no avail, The Associated Press reports.

The World Health Organisation draws up a plan to try to tackle the "alarming" problem of drug-resistant tuberculosis in 53 European countries.

(University Hospitals Case Medical Center) University Hospitals (UH) Case Medical Center will begin a Phase 1 study on a new experimental anti-tuberculosis drug called TMC207.

This drug represents the first new class of anti-TB drugs in the past 60 years and it has activity against both drug-susceptible and drug-resistant TB.

(Albert Einstein College of Medicine) The National Institutes of Health has awarded scientists at Albert Einstein College of Medicine of Yeshiva University a five-year, $3.9 million grant to study how extensively drug-resistant tuberculosis (XDR-TB) is transmitted in rural South Africa.

The findings could alter public health approaches for controlling the XDR-TB epidemic in the developing world.

LONDON (AP) -- The World Health Organization says it doesn't have enough information to know if it is winning the fight against drug-resistant tuberculosis....

LANTANA, Fla. (AP) -- It started with a cough, an autumn hack that refused to go away....

ATLANTA (MedPage Today) -- Better tuberculosis and HIV control has led to a decline in extensively drug-resistant TB in the U.S., according to CDC researchers here.

GENEVA -- State-of-the-art diagnostic tests for multidrug-resistant tuberculosis, as well as drugs for treating it, will be made available to certain African and Asian nations under two new programs announced here.